glp 1 drug history GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art History of GLP-1: From Discovery

This is where the landscape has shifted dramatically in recent years

December 2, 2024: Lawsuits Against Zepbound and Other GLP-1 Drugs Reach 1,300 1,300 people have filed lawsuits against Zepbound manufacturer Eli Lilly and Company and other GLP-1 drug manufacturers alleging that these drugs have a range of severe side effects

This is where most concentration confusion begins

Green, Michael

Current Recommendations In October 2024, the ASA issued an Affirmation of Value for a more recent multisociety guidance document on GLP-1 receptor agonists

The development of multiagonists, including GLP-1glucagon and GIPGLP-1glucagon receptor agonists, especially with the potential for glucagon receptor activation, marks a significant advancement in the field